Cancer Gene Therapies
Agreement To License MDA-7 Tumor Suppressor Gene Announced
Published in Cancer Weekly, March 30th, 1998
GenQuest receives an up-front payment, and if the option is exercised by Introgen, also receives undisclosed research funding, milestone payments and royalties on potential product sales.
GenQuest holds exclusive worldwide rights to the mda-7 gene. Preclinical data suggest that mda-7 is a universal tumor suppressor gene. Expression of this gene in a variety of different tumor cells results in loss of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-03-30)
More Articles from Cancer Weekly
- Cancer Gene Therapy
Two Strategies Against Pancreatic Cancer Explored at Conference - Cancer Gene Therapy
bax Overexpression Induces Apoptosis in Breast Cancer Cells - Cancer Gene Therapy
Adenovirus-Mediated Gene Therapy Looks Promising against Thyroid Cancer - Cancer Immunotherapy
p53 Stimulated Cytotoxic T Cells Target Bladder Cancer In Vivo - Cancer Immunotherapy
IL-2 Successfully Incorporated in Immuno-Gene Therapy Strategies - Prostate Cancer
Immunotherapy and Gene Therapy Used against Prostate Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
